Inventiva S.A.
IVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001756594
No open-market purchases or sales by Inventiva S.A. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $319.5M in total; no superinvestor holds it.
Other share classesIVEVF
Q4 2021 vs. Q3 2021
How the institutions holding Inventiva S.A. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 12 | 10 | −2 |
| Shares | 3.71M | 3.76M | +47.2K (+1.3%) |
| Value | $52.5M | $51.3M | −$1.20M (−2.3%) |
New holders (2)
Institutions that held Inventiva S.A. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Fortitude Advisory Group L.L.C. | 133 | $2.00K | 0.00% |
| CWM, LLC | 100 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Inventiva S.A. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Credit Suisse AG | 35,860 | $507.0K |
| Maven Securities LTD | 25,000 | $354.0K |
| Millennium Management LLC | 10,008 | $142.0K |
| Geneos Wealth Management Inc. | 100 | $1.00K |